OTC Antihistamine Tablets Recalled for Failed Quality Specifications
L. Perrigo Company is recalling 1,920 cartons of Exchange Select Aller Ease (Fexofenadine Hydrochloride) 180 mg tablets nationwide due to failed impurity and degradation specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The issue is failed impurities and degradation specifications, indicating a manufacturing quality control failure rather than an acute safety hazard. This is a precautionary recall.
Plain-English summary
L. Perrigo Company is recalling 1,920 cartons of Exchange Select Aller Ease (Fexofenadine Hydrochloride) 180 mg tablets due to failed impurities and degradation specifications. The affected lot is 2ER0285 with an expiration date of January 2024, and the product was distributed nationwide through military exchanges.
The product failed to meet regulatory specifications for impurities and degradation during quality testing. No illnesses or injuries have been reported in connection with this product.
Consumers who have purchased this product should stop using it and contact their healthcare provider or pharmacist with any questions. Customers may return the product to the point of sale for a refund or replacement.
The recalled product
- Product
- EXCHANGE SELECT ALLER EASE (FEXOFENADINE HYDROCHLORIDE)
- Brand
- EXCHANGE SELECT ALLER EASE
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Antihistamine
- Hazard
- impurity
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2ER0285
- Exp. date 01/24
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27